Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes

被引:14
|
作者
Kraeima, J. [1 ,2 ]
Siesling, S. [1 ,3 ]
Vliegen, I. M. H. [2 ]
Klaase, J. M. [4 ]
IJzerman, M. J. [1 ]
机构
[1] Univ Twente, Dept Hlth Technol & Serv Res HTSR, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands
[2] CTIT, CHOIR, NL-7500 AE Enschede, Netherlands
[3] Comprehens Canc Ctr Netherlands IKNL, Dept Registrat & Res, NL-3511 GD Utrecht, Netherlands
[4] Med Spectrum Twente, Dept Surg, NL-7500 KA Enschede, Netherlands
关键词
breast cancer; follow-up; locoregional recurrence; prognostic factor; personalised medicine; CLINICAL-PRACTICE GUIDELINES; CONSERVING THERAPY; TUMOR RECURRENCE; EORTC; 10801; MASTECTOMY; IMPACT; MAMMOGRAPHY; VALIDATION; CARE;
D O I
10.1038/bjc.2013.401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer follow-up is not tailored to the risk of locoregional recurrences (LRRs) in individual patients or as a function of time. The objective of this study was to identify prognostic factors and to estimate individual and time-dependent LRR risk rates. Methods: Prognostic factors for LRR were identified by a scoping literature review, expert consultation, and stepwise multivariate regression analysis based on 5 years of data from women diagnosed with breast cancer in the Netherlands in 2005 or 2006 (n = 17 762). Inter-patient variability was elucidated by examples of 5-year risk profiles of average-, medium-, and high-risk patients, whereby 6-month interval risks were derived from regression estimates. Results: Eight prognostic factors were identified: age, tumour size, multifocality, gradation, adjuvant chemo-, adjuvant radiation-, hormonal therapy, and triple-negative receptor status. Risk profiles of the low-, average-, and high-risk example patients showed non-uniform distribution of recurrence risks (2.9, 7.6, and 9.2%, respectively, over a 5-year period). Conclusion: Individual risk profiles differ substantially in subgroups of patients defined by prognostic factors for recurrence and over time as defined in 6-month time intervals. To tailor follow-up schedules and to optimise allocation of scarce resources, risk factors, frequency, and duration of follow-up should be taken into account.
引用
收藏
页码:866 / 871
页数:6
相关论文
empty
未找到相关数据